Project Grant G11AI183359
Award Date
8/6/24
Completion Date
1/31/26
Dollars Obligated
$113K
Federal Agency
National Institute of Allergy and Infectious Diseases
Federal Grant Program
93.855
Assistance Type
Project Grant
Place of Performance
Nigeria
Similar Awards
The federal Project Grant award of $101,290 from the National Institute of Allergy and Infectious Diseases (CFDA 93.855 - Allergy and Infectious Diseases Research) aims to strengthen grants administration capacity at the Makerere University College of Health Sciences in Uganda. The key products and services to be delivered under this award include: Providing advanced training and mentorship to senior research administrators at Makerere University on best practices for pre- and post-award...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $108,000 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to Kenyatta National Hospital (KNH) in Kenya. The purpose of this 2-year grant, with an award date of August 1, 2024 and a completion date of January 31, 2026, is to strengthen KNH's pre-award grants management capacity. The key products and services to be delivered through this funding include: 1) Training two senior research...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $149,041 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to The University of Southern Mississippi. The grant supports the development of novel assays to differentiate and measure the secretion of membrane-bound and soluble forms of tumor necrosis factor (TNF), which play distinct roles in inflammatory and autoimmune diseases. The objectives are to establish a fluorescence-based...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $242,185 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to Texas A&M Agrilife Research. The grant supports research to investigate the role of RNA structure in regulating developmental RNA editing in pathogenic trypanosomes, such as Trypanosoma brucei. The key objectives are to: 1) Develop a new technique to assess RNA structure under native cellular conditions versus in vitro,...
This federal Project Grant award of $107,699 from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), aims to strengthen administrative and financial oversight of NIAID grants at the Instituto de Efectividad Clinica y Sanitaria (IECS) and other research institutions in South America. The primary objectives are to: 1) Build IECS' capacity to properly manage NIAID/NIH grants in accordance with regulations,...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $483,194 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to the Research Institute at Nationwide Children's Hospital. The grant, with a project period from March 2025 to February 2030, aims to define the protective CD4+ T cell response that supports effective CD8+ T cell immunity against the Hepatitis C Virus (HCV). The research will leverage historical blood and liver samples...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $198,720 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to The Johns Hopkins University to improve early detection of yellow fever outbreaks in Ghana. The 5-year grant, awarded on Jul 1, 2025, will support the development of subnational risk maps for yellow fever, quantification of patient and specimen delays in yellow fever diagnostics, and comparison of cost-effective...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $402,731 Project Grant under the Allergy and Infectious Diseases Research federal grant program (CFDA 93.855) to the University of Washington. The objective of this R38 grant is to increase the number of next generation physician-scientists who can apply knowledge of microbiology, immunology, and research techniques to improve reproductive, maternal, and child health. The grant will support 4 physician-scientists in...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a Project Grant valued at $718,758 to the Texas Biomedical Research Institute under the Allergy and Infectious Diseases Research program (CFDA 93.855). The grant is focused on evaluating the use of IL-21-IgFc fusion protein as a host-directed immunotherapy to improve immune reconstitution and reduce the risk of latent tuberculosis (TB) reactivation in Mycobacterium tuberculosis (MTB) and simian immunodeficiency virus (SIV)...
This Project Grant award of $1,454,386.00 from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), supports fundamental research to better understand the epigenetic regulation of the HIV-1 viral RNA cap. The research aims to define the structural basis of HIV cap hypermethylation and its linkage to modulating host innate immune signaling, with the goal of developing new treatments to neutralize deleterious...